Incorporating Surrogate Endpoints into Group Sequential Trials (Q4717723)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Incorporating Surrogate Endpoints into Group Sequential Trials |
scientific article; zbMATH DE number 952849
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Incorporating Surrogate Endpoints into Group Sequential Trials |
scientific article; zbMATH DE number 952849 |
Statements
Incorporating Surrogate Endpoints into Group Sequential Trials (English)
0 references
5 January 1997
0 references
